Repligen Corp at Barclays Global Healthcare Conference (Virtual) Transcript
Great. We're live. It's Luke Sergott. There we go. We're live. I'm Luke Sergott. I cover life science tools and diagnostics here at Barclays. My pleasure to have Repligen's CFO, Jon Snodgres with us. I think he's going to go through a couple of slides here, and then we'll dive into some questions. And with that, Jon, go ahead and take it away. Thanks for coming.
All right. Thank you, Luke, and good afternoon, everybody. Appreciate the time this morning. I'll give you a little bit of an overview on what we're up to at Repligen these days and our progress towards becoming a premier bioprocessing company. So before I jump into the slides, I wanted to chat a little bit about some of the important trends we're seeing in the bioprocessing market these days. And these are all about increasing overall efficiency and increasing overall productivity really around the manufacturing processes.
So the first real trend that we're seeing is the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |